February 1, 2013
The GAP1 xenograft project will be of two years duration and will ultimately be a single unified global project that will involve researchers from around the world collaborating as a team to integrate their xenograft activities to maximise the value of patient cohorts. The aim is to assist in characterization and utility of existing prostate cancer xenografts and to produce new highly valuable prostate cancer xenograft models that can facilitate a better understanding of metastasis, treatment response and treatment resistance in castration resistant prostate cancer.